Group One Trading
PTGX icon

Group One Trading’s Protagonist Therapeutics PTGX Stock Holding History

Group One Trading’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.01M Buy
+38,000
New +$3.36M 0.01% 1473
2025
Q4 		– Sell
-4,400
Closed -$292K – 8958
2025
Q3 		$292K Sell
4,400
-9,500
-68% -$540K ﹤0.01% 4250
2025
Q2 		$768K Sell
13,900
-48,800
-78% -$2.34M ﹤0.01% 3006
2025
Q1 		$3.03M Buy
62,700
+62,500
+31,250% +$2.62M 0.01% 1467
2024
Q4 		$7.72K Buy
+200
New +$8.72K ﹤0.01% 6223
2024
Q3 		– Sell
-66,000
Closed -$2.29M – 7224
2024
Q2 		$2.29M Sell
66,000
-32,600
-33% -$955K 0.01% 1338
2024
Q1 		$2.85M Buy
+98,600
New +$2.68M 0.01% 1231
2023
Q4 		– Sell
-12,000
Closed -$200K – 8044
2023
Q3 		$200K Buy
12,000
+8,100
+208% +$157K ﹤0.01% 3806
2023
Q2 		$108K Sell
3,900
-19,600
-83% -$491K ﹤0.01% 4543
2023
Q1 		$541K Buy
+23,500
New +$395K ﹤0.01% 2708
2022
Q3 		– Sell
-67,900
Closed -$537K – 8091
2022
Q2 		$537K Buy
67,900
+16,100
+31% +$195K ﹤0.01% 3358
2022
Q1 		$1.23M Buy
51,800
+51,500
+17,167% +$1.45M ﹤0.01% 2880
2021
Q4 		$10K Buy
+300
New +$9.48K ﹤0.01% 7352
2021
Q3 		– Sell
-600
Closed -$27K – 8667
2021
Q2 		$27K Buy
+600
New +$19.8K ﹤0.01% 7016

Other funds holding PTGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Group One Trading's PTGX Position: Q1 2025 in Review

Group One Trading sold out of Protagonist Therapeutics (PTGX) in Q1 2025, closing a stake of 70 shares — an estimated $2.93K sold.

Group One Trading first reported a position in PTGX in Q3 2021 and held it in 8 quarters. The position peaked at $821K in Q1 2024. 275 funds tracked by Wall St. Rank hold PTGX as of Q1 2025.

  • Group One Trading reported no remaining Protagonist Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 70 Protagonist Therapeutics shares in Q1 2025, an estimated $2.93K.
  • Group One Trading first reported a position in Protagonist Therapeutics in Q3 2021 and held it in 8 quarters.
  • Group One Trading's Protagonist Therapeutics position peaked at $821K in Q1 2024.
  • 275 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.